219 related articles for article (PubMed ID: 1603491)
41. A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc.
Harlow BL; Weiss NS
Am J Epidemiol; 1989 Aug; 130(2):390-4. PubMed ID: 2750733
[TBL] [Abstract][Full Text] [Related]
42. Association between frequency and intensity of recreational physical activity and epithelial ovarian cancer risk by age period.
Carnide N; Kreiger N; Cotterchio M
Eur J Cancer Prev; 2009 Aug; 18(4):322-30. PubMed ID: 19390450
[TBL] [Abstract][Full Text] [Related]
43. Ovarian cancer and occupational exposure among pulp and paper employees in Norway.
Langseth H; Kjaerheim K
Scand J Work Environ Health; 2004 Oct; 30(5):356-61. PubMed ID: 15529799
[TBL] [Abstract][Full Text] [Related]
44. Genital powder exposure and the risk of epithelial ovarian cancer.
Rosenblatt KA; Weiss NS; Cushing-Haugen KL; Wicklund KG; Rossing MA
Cancer Causes Control; 2011 May; 22(5):737-42. PubMed ID: 21516319
[TBL] [Abstract][Full Text] [Related]
45. Prospective study of talc use and ovarian cancer.
Gertig DM; Hunter DJ; Cramer DW; Colditz GA; Speizer FE; Willett WC; Hankinson SE
J Natl Cancer Inst; 2000 Feb; 92(3):249-52. PubMed ID: 10655442
[TBL] [Abstract][Full Text] [Related]
46. Perineal powder use and risk of endometrial cancer in postmenopausal women.
Crawford L; Reeves KW; Luisi N; Balasubramanian R; Sturgeon SR
Cancer Causes Control; 2012 Oct; 23(10):1673-80. PubMed ID: 22875750
[TBL] [Abstract][Full Text] [Related]
47. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
[TBL] [Abstract][Full Text] [Related]
48. Re: "Perineal powder exposure and the risk of ovarian cancer".
Muscat JE; Wynder EL
Am J Epidemiol; 1997 Nov; 146(9):786. PubMed ID: 9366627
[No Abstract] [Full Text] [Related]
49. The relationship between perineal cosmetic talc usage and ovarian talc particle burden.
Heller DS; Westhoff C; Gordon RE; Katz N
Am J Obstet Gynecol; 1996 May; 174(5):1507-10. PubMed ID: 9065120
[TBL] [Abstract][Full Text] [Related]
50. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
Terry KL; Karageorgi S; Shvetsov YB; Merritt MA; Lurie G; Thompson PJ; Carney ME; Weber RP; Akushevich L; Lo-Ciganic WH; Cushing-Haugen K; Sieh W; Moysich K; Doherty JA; Nagle CM; Berchuck A; Pearce CL; Pike M; Ness RB; Webb PM; ; ; Rossing MA; Schildkraut J; Risch H; Goodman MT;
Cancer Prev Res (Phila); 2013 Aug; 6(8):811-21. PubMed ID: 23761272
[TBL] [Abstract][Full Text] [Related]
51. Perineal talc use and ovarian cancer: a critical review.
Muscat JE; Huncharek MS
Eur J Cancer Prev; 2008 Apr; 17(2):139-46. PubMed ID: 18287871
[TBL] [Abstract][Full Text] [Related]
52. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.
Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M
Am J Epidemiol; 1988 Dec; 128(6):1228-40. PubMed ID: 3195564
[TBL] [Abstract][Full Text] [Related]
53. Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam.
Sokal DC; Vach TH; Nanda K; McCann MF; Weiner DH; Drobnes C; Rochanawutanon M; Duc NB; Loan ND
Epidemiology; 2010 Mar; 21(2):164-71. PubMed ID: 20160560
[TBL] [Abstract][Full Text] [Related]
54. Douching, Talc Use, and Risk of Ovarian Cancer.
Gonzalez NL; O'Brien KM; D'Aloisio AA; Sandler DP; Weinberg CR
Epidemiology; 2016 Nov; 27(6):797-802. PubMed ID: 27327020
[TBL] [Abstract][Full Text] [Related]
55. Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.
Davis CP; Bandera EV; Bethea TN; Camacho F; Joslin CE; Wu AH; Beeghly-Fadiel A; Moorman PG; Myers ER; Ochs-Balcom HM; Peres LC; Rosenow WT; Setiawan VW; Rosenberg L; Schildkraut JM; Harris HR
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1660-1668. PubMed ID: 34155063
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of women who use perineal powders.
Rosenblatt KA; Mathews WA; Daling JR; Voigt LF; Malone K
Obstet Gynecol; 1998 Nov; 92(5):753-6. PubMed ID: 9794663
[TBL] [Abstract][Full Text] [Related]
57. Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer.
Tzonou A; Polychronopoulou A; Hsieh CC; Rebelakos A; Karakatsani A; Trichopoulos D
Int J Cancer; 1993 Sep; 55(3):408-10. PubMed ID: 8375924
[TBL] [Abstract][Full Text] [Related]
58. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
[TBL] [Abstract][Full Text] [Related]
59. Douching, Talc Use, and Risk for Ovarian Cancer and Conditions Related to Genital Tract Inflammation.
Gabriel IM; Vitonis AF; Welch WR; Titus L; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1835-1844. PubMed ID: 31455671
[TBL] [Abstract][Full Text] [Related]
60. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.
Merritt MA; Green AC; Nagle CM; Webb PM; ;
Int J Cancer; 2008 Jan; 122(1):170-6. PubMed ID: 17721999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
